Currently 1 bullish, 1 bearish — stable.
Analysts are holding steady at 1 bullish to 1 bearish.
2 YouTube analysts cover Nutrien Ltd. (NTR).
2 analysts have covered NTR so far…
Nutrien is presented as a value-quadrant buy with the upside in the market’s repricing.
He lists Nutrien in the same quadrant as other buys and references strong realized moves for those picks. The takeaway is that NTR’s attractiveness comes from fundamentals aligning with a better valuation entry.
Nutrient (NTR) is viewed as a possible fertilizer bet, but confidence drops because fertilizer’s margin outlook is unclear over multi-year horizons.
The argument points to investors hesitating because today’s fertilizer margins may not hold in “a year two years three years five years.” That framing weakens NTR’s appeal as a long-term allocation, since fertilizer build-out is called “a herculean effort.”
NTR is a well-run, low-cost potash/retail cash-flow compounder with a ~3% dividend and meaningful Agrium merger benefits, but after the rebound it's now fairly priced (closer to ~6% FCF yield vs his ~10% target) and the Jansen delay + future BHP potash supply risk mean the better risk/reward is waiting for a deeper pullback.
After rebounding, Nutrien’s free cash flow yield has compressed toward 6% versus the analyst’s roughly 10% target, reducing the risk-reward despite strong potash cost advantages and Agrium merger benefits. The Jansen project delay and emerging BHP potash supply risk support waiting for a deeper pullback.
No official filings surfaced for NTR yet.
